Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Rijken

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Thrombosis and Haemostasis|April 7, 1987
Increased plasminogen activator inhibition levels in malignancyE de Jong, E A Knot, D Piket, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2012
Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis testsD C Rijken, E L Kock, A H C Guimarães, et al.
Circulation|January 7, 1997
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activatorE A Biessen, M van Teijlingen, H Vietsch, et al.
The Journal of Biological Chemistry|November 8, 1996
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentrationE A Biessen, F Noorman, M E van Teijlingen, et al.
Biochemical and Biophysical Research Communications|September 25, 2012
Binding of carboxypeptidase N to fibrinogen and fibrinS Talens, J H G Lebbink, J J M C Malfliet, et al.
Journal of Thrombosis and Haemostasis : JTH|August 12, 2005
High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic strokeF W G Leebeek, M P J Goor, A H C Guimaraes, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in childrenM Emonts, E L E de Bruijne, A H C Guimarães, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2009
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC studyE L E de Bruijne, A Gils, A H C Guimarães, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2011
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand diseaseE M De Wee, K Klaij, H C J Eikenboom, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2017
Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand diseaseS Abdul, J Boender, J J M C Malfliet, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Thrombosis and Haemostasis|April 7, 1987
Increased plasminogen activator inhibition levels in malignancyE de Jong, E A Knot, D Piket, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2012
Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis testsD C Rijken, E L Kock, A H C Guimarães, et al.
Circulation|January 7, 1997
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activatorE A Biessen, M van Teijlingen, H Vietsch, et al.
The Journal of Biological Chemistry|November 8, 1996
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentrationE A Biessen, F Noorman, M E van Teijlingen, et al.
Biochemical and Biophysical Research Communications|September 25, 2012
Binding of carboxypeptidase N to fibrinogen and fibrinS Talens, J H G Lebbink, J J M C Malfliet, et al.
Journal of Thrombosis and Haemostasis : JTH|August 12, 2005
High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic strokeF W G Leebeek, M P J Goor, A H C Guimaraes, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in childrenM Emonts, E L E de Bruijne, A H C Guimarães, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2009
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC studyE L E de Bruijne, A Gils, A H C Guimarães, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2011
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand diseaseE M De Wee, K Klaij, H C J Eikenboom, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2017
Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand diseaseS Abdul, J Boender, J J M C Malfliet, et al.
Pageof 11